Skip to search formSkip to main contentSkip to account menu

A-56268

Known as: A 56268, A56268, Abbott-56268 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Clarithromycin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1992
1992
Individual efficacy of clarithromycin (A-56268) and its major human metabolite 14-hydroxy clarithromycin (A-62671) in experimental pneumococcal pneumonia in the mouse.
In man, clarithromycin (A-56268) is metabolized to a 14-hydroxy derivative (14-OH clarithromycin, A-62671); this metabolite is… 
1989
1989
[Long-term administration study on TE-031 (A-56268) in the treatment of diffuse panbronchiolitis].
TE-031 (A-56268), a new macrolide antibiotics, was administered on a long-term basis (6 months) to 12 patients with diffuse… 
Highly Cited
1989
Highly Cited
1989
Susceptibility of Legionella pneumophila to eight antimicrobial agents including four macrolides under different assay conditions.
A comparison of agar dilution and microdilution susceptibility testing for eight antimicrobial agents, including roxithromycin… 
1989
1989
A new macrolide, TE-031 (A-56268), in treatment of experimental Legionnaires' disease.
The activity of a new macrolide, TE-031 (A-56268), against Legionella pneumophila in vitro was superior to the activities of… 
Highly Cited
1988
Highly Cited
1988
In vitro activities of azithromycin (CP 62,993), clarithromycin (A-56268; TE-031), erythromycin, roxithromycin, and clindamycin
The in vitro activity of azithromycin (CP 62,993 or XZ-450) against Haemophilus influenzae was greater than that of three other… 
1988
1988
Activity of A-56268 (TE-031), a new macrolide, against Toxoplasma gondii in mice.
The activity of A-56268 (TE-031), a new macrolide, was tested in a murine model of acute toxoplasmosis. All control animals died… 
1988
1988
Comparative in-vitro activities of A-56268 (TE-031) and erythromycin against 306 clinical isolates.
The inhibitory (MIC) and bactericidal (MBC) activities of a new macrolide A-56268 (TE-031) against 306 clinical aerobic bacterial… 
1987
1987
In vitro activity of A-56268 (TE-031), a new macrolide, compared with that of erythromycin and clindamycin against selected gram-positive and gram-negative organisms
The in vitro activity of A-56268 was determined and compared with that of erythromycin and clindamycin against a limited spectrum… 
1987
1987
Comparative in-vitro activity of A-56268 (TE-031), a new macrolide antibiotic.
The comparative in-vitro activity of A-56268 (TE-031), a new semisynthetic macrolide antibiotic, was assessed against… 
1987
1987
Regression analysis, proposed interpretative zone size standards, and quality control guidelines for a new macrolide antimicrobial agent, A-56268 (TE-031)
A-56268 is a 6-O-methyl derivative of erythromycin A which has a spectrum of activity similar to that of erythromycin and is 1… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)